48,817 Dead and 5,107,883 Injured Following COVID-19 Vaccines in European Database of Adverse Reactions

By Brian Shilhavy
Global Research, November 18, 2022
Health Impact News 17 November 2022
Region:
Theme:

All Global Research articles can be read in 51 languages by activating the Translate Website button below the author’s name.

To receive Global Research’s Daily Newsletter (selected articles), click here.

Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

***

The European (EEA and non-EEA countries) database of suspected drug reaction reports is EudraVigilance, verified by the European Medicines Agency (EMA), and they are now reporting 48,817 fatalities, and 5,107,883 injuries following injections of four experimental COVID-19 shots:

From the total of injuries recorded, almost half of them (2,177,286) are serious injuries.

“Seriousness provides information on the suspected undesirable effect; it can be classified as ‘serious’ if it corresponds to a medical occurrence that results in death, is life-threatening, requires inpatient hospitalisation, results in another medically important condition, or prolongation of existing hospitalisation, results in persistent or significant disability or incapacity, or is a congenital anomaly/birth defect.”

A Health Impact News subscriber in Europe ran the reports for each of the four COVID-19 shots we are including here. It is a lot of work to tabulate each reaction with injuries and fatalities, since there is no place on the EudraVigilance system we have found that tabulates all the results.

Since we have started publishing this, others from Europe have also calculated the numbers and confirmed the totals.*

Here is the summary data through November 12, 2022.

Total reactions for the mRNA vaccine Tozinameran (code BNT162b2,Comirnaty) from BioNTech/ Pfizer – 23,210 deaths and 2,667,243 injuries to 12/11/2022:

  • 79,297   Blood and lymphatic system disorders incl. 335 deaths
  • 90,887   Cardiac disorders incl. 3,351 deaths
  • 842        Congenital, familial and genetic disorders incl. 66 deaths
  • 33,754   Ear and labyrinth disorders incl. 22 deaths
  • 3,497     Endocrine disorders incl. 13 deaths
  • 38,206   Eye disorders incl. 64 deaths
  • 184,670 Gastrointestinal disorders incl. 915 deaths
  • 688,114 General disorders and administration site conditions incl. 6,286 deaths
  • 3,020     Hepatobiliary disorders incl. 133 deaths
  • 28,472   Immune system disorders incl. 156 deaths
  • 183,898 Infections and infestations incl. 2,392 deaths
  • 46,012   Injury, poisoning and procedural complications incl. 551 deaths
  • 63,046   Investigations incl. 630 deaths
  • 16,685   Metabolism and nutrition disorders incl. 406 deaths
  • 298,841 Musculoskeletal and connective tissue disorders incl. 331 deaths
  • 3,302     Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 301 deaths
  • 407,210 Nervous system disorders incl. 2,482 deaths
  • 3,515     Pregnancy, puerperium and perinatal conditions incl. 83 deaths
  • 342        Product issues incl. 4 deaths
  • 46,792   Psychiatric disorders incl. 267 deaths
  • 9,544     Renal and urinary disorders incl. 352 deaths
  • 117,187 Reproductive system and breast disorders incl. 11 deaths
  • 107,494 Respiratory, thoracic and mediastinal disorders incl. 2,481 deaths
  • 117,035 Skin and subcutaneous tissue disorders incl. 207 deaths
  • 7,110     Social circumstances incl. 30 deaths
  • 29,524   Surgical and medical procedures incl. 309 deaths
  • 58,947   Vascular disorders incl. 1,032 deaths

Total reactions for the mRNA vaccine SPIKEVAX/mRNA-1273(CX-024414) from Moderna – 12,703 deaths and 870,106 injuries to 12/11/2022:

  • 23,093   Blood and lymphatic system disorders incl. 152 deaths
  • 30,044   Cardiac disorders incl. 1,415 deaths
  • 269        Congenital, familial and genetic disorders incl. 16 deaths
  • 10,043   Ear and labyrinth disorders incl. 8 deaths
  • 951        Endocrine disorders incl. 6 deaths
  • 11,407   Eye disorders incl. 42 deaths
  • 67,342   Gastrointestinal disorders incl. 487 deaths
  • 229,166 General disorders and administration site conditions incl. 4,057 deaths
  • 1,148     Hepatobiliary disorders incl. 69 deaths
  • 9,547     Immune system disorders incl. 46 deaths
  • 38,244   Infections and infestations incl. 1,153 deaths
  • 12,405   Injury, poisoning and procedural complications incl. 250 deaths
  • 19,071   Investigations incl. 413 deaths
  • 6,813     Metabolism and nutrition disorders incl. 300 deaths
  • 107,976 Musculoskeletal and connective tissue disorders incl. 251 deaths
  • 1,156     Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 115 deaths
  • 142,329 Nervous system disorders incl. 1,231 deaths
  • 1,154     Pregnancy, puerperium and perinatal conditions incl. 13 deaths
  • 149        Product issues incl. 3 deaths
  • 14,434   Psychiatric disorders incl. 201 deaths
  • 4,428     Renal and urinary disorders incl. 244 deaths
  • 25,857   Reproductive system and breast disorders incl. 11 deaths
  • 34,767   Respiratory, thoracic and mediastinal disorders incl. 1,337 deaths
  • 45,736   Skin and subcutaneous tissue disorders incl. 118 deaths
  • 3,412     Social circumstances incl. 46 deaths
  • 11,812   Surgical and medical procedures incl. 228 deaths
  • 17,353   Vascular disorders incl. 491 deaths

Total reactions for the vaccine AZD1222/VAXZEVRIA (CHADOX1 NCOV-19) from Oxford/ Astra Zeneca  – 9,667deaths and 1,388,494 injuries to 12/11/2022:

  • 15,933   Blood and lymphatic system disorders incl. 360 deaths
  • 24,615   Cardiac disorders incl. 1,012 deaths
  • 298        Congenital familial and genetic disorders incl. 12 deaths
  • 15,431   Ear and labyrinth disorders incl. 8 deaths
  • 876        Endocrine disorders incl. 8 deaths
  • 22,942   Eye disorders incl. 34 deaths
  • 123,551 Gastrointestinal disorders incl. 511 deaths
  • 376,016 General disorders and administration site conditions incl. 2,239 deaths
  • 1,253     Hepatobiliary disorders incl. 91 deaths
  • 7,141     Immune system disorders incl. 49 deaths
  • 59,884   Infections and infestations incl. 818 deaths
  • 15,929   Injury poisoning and procedural complications incl. 239 deaths
  • 33,678   Investigations incl. 228 deaths
  • 15,264   Metabolism and nutrition disorders incl. 150 deaths
  • 201,842 Musculoskeletal and connective tissue disorders incl. 199 deaths
  • 969        Neoplasms benign malignant and unspecified (incl cysts and polyps) incl. 65 deaths
  • 276,325 Nervous system disorders incl. 1,402 deaths
  • 740        Pregnancy puerperium and perinatal conditions incl. 23 deaths
  • 216        Product issues incl. 1 death
  • 24,640   Psychiatric disorders incl. 88 deaths
  • 5,020     Renal and urinary disorders incl. 107 deaths
  • 18,719   Reproductive system and breast disorders incl. 3 deaths
  • 48,116   Respiratory thoracic and mediastinal disorders incl. 1,271 deaths
  • 60,805   Skin and subcutaneous tissue disorders incl. 81 deaths
  • 2,537     Social circumstances incl. 11 deaths
  • 3,529     Surgical and medical procedures incl. 45 deaths
  • 32,225   Vascular disorders incl. 612 deaths

Total reactions for the COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson – 3,234 deaths and 178,053 injuries to 12/11/2022:

  • 1,794     Blood and lymphatic system disorders incl. 72 deaths
  • 3,948     Cardiac disorders incl. 267 deaths
  • 64           Congenital, familial and genetic disorders incl. 3 deaths
  • 1,946     Ear and labyrinth disorders incl. 3 deaths
  • 164        Endocrine disorders incl. 2 deaths
  • 2,337     Eye disorders incl. 16 deaths
  • 11,933   Gastrointestinal disorders incl. 129 deaths
  • 49,033   General disorders and administration site conditions incl. 897 deaths
  • 221        Hepatobiliary disorders incl. 23 deaths
  • 848        Immune system disorders incl. 12 deaths
  • 16,007   Infections and infestations incl. 273 deaths
  • 1,699     Injury, poisoning and procedural complications incl. 38 deaths
  • 8,184     Investigations incl. 171 deaths
  • 1,142     Metabolism and nutrition disorders incl. 88 deaths
  • 22,051   Musculoskeletal and connective tissue disorders incl. 74 deaths
  • 160        Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 14 deaths
  • 30,257   Nervous system disorders incl. 317 deaths
  • 135        Pregnancy, puerperium and perinatal conditions incl. 1 death
  • 38           Product issues
  • 2,651     Psychiatric disorders incl. 37 deaths
  • 773        Renal and urinary disorders incl. 53 deaths
  • 4,159     Reproductive system and breast disorders incl. 7 deaths
  • 6,227     Respiratory, thoracic and mediastinal disorders incl. 405 deaths
  • 5,438     Skin and subcutaneous tissue disorders incl. 17 deaths
  • 718        Social circumstances incl. 8 deaths
  • 1,332     Surgical and medical procedures incl. 104 deaths
  • 4,794     Vascular disorders incl. 203 deaths

Total reactions for the COVID-19 vaccine NUVAXOVID(NVX-COV2373) from Novavax – 3 deaths and 3,987 injuries to 12/11/2022:

  • 90           Blood and lymphatic system disorders
  • 243        Cardiac disorders
  • 0             Congenital familial and genetic disorders
  • 56           Ear and labyrinth disorders
  • 1             Endocrine disorders
  • 82           Eye disorders
  • 262        Gastrointestinal disorders
  • 861        General disorders and administration site conditions incl. 1 death
  • 5             Hepatobiliary disorders
  • 41           Immune system disorders
  • 205        Infections and infestations
  • 43           Injury poisoning and procedural complications
  • 107        Investigations
  • 22           Metabolism and nutrition disorders
  • 497        Musculoskeletal and connective tissue disorders
  • 2             Neoplasms benign malignant and unspecified (incl cysts and polyps)
  • 705        Nervous system disorders
  • 2             Pregnancy puerperium and perinatal conditions
  • 3             Product issues
  • 67           Psychiatric disorders
  • 21           Renal and urinary disorders
  • 78           Reproductive system and breast disorders
  • 204        Respiratory thoracic and mediastinal disorders incl. 1 death
  • 255        Skin and subcutaneous tissue disorders
  • 7             Social circumstances
  • 34           Surgical and medical procedures
  • 94           Vascular disorders incl. 1 death

*These totals are estimates based on reports submitted to EudraVigilance. Totals may be much higher based on percentage of adverse reactions that are reported. Some of these reports may also be reported to the individual country’s adverse reaction databases, such as the U.S. VAERS database and the UK Yellow Card system. The fatalities are grouped by symptoms, and some fatalities may have resulted from multiple symptoms.

Sudden Deaths and Injuries Among Young and Formerly Healthy People Continue

24-Year-Old British Professional Athlete and Actress Genevieve Florence. (Left 2 image sources.)

Sudden deaths and injuries continue to be reported all across Europe and around the world, and more and more European politicians are beginning to speak out about how deadly the COVID-19 vaccines are.

But instead of halting these vaccines, the EMA has actually just approved a new COVID-19 vaccine by GSK and Sanofi.

After months of review at European regulators’ desks, GSK and Sanofi have scored a world-first nod to enter the COVID-19 vaccine market in Europe with their pandemic booster VidPrevtyn Beta.

Thursday, the European Commission signed off on the Sanofi-GSK booster to augment protection against COVID-19 in adults ages 18 and up, making VidPrevtyn the first next-gen, protein-based adjuvanted COVID-19 vaccine approved in Europe. (Full article.)

Australia has done the exact opposite, and has stated they are NOT approving new COVID-19 boosters for those under the age of 30 due to the high risks of heart disease from the shots.

The Australian government says the risk of myocarditis from a COVID booster might be greater than COVID itself — so it won’t allow people under 30 to get a fourth vaccine.

“In males aged 16-40 years, it is uncertain whether the risk following COVID-19 remains higher than the risk following vaccination,” the government said. (Full article.)

Here is the latest montage of young victims who have either suffered “sudden deaths” or crippling injuries. It starts with the testimony of 24-year-old British professional athlete and actress Genevieve Florence, who was mandated to get the shots to be able to continue filming, and totally disabled her.

This is on our Bitchute channel, and will also be on our Odysee and Telegram channels.

*

Note to readers: Please click the share buttons above. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

Featured image is from Children’s Health Defense

The Worldwide Corona Crisis, Global Coup d’Etat Against Humanity

by Michel Chossudovsky

Michel Chossudovsky reviews in detail how this insidious project “destroys people’s lives”. He provides a comprehensive analysis of everything you need to know about the “pandemic” — from the medical dimensions to the economic and social repercussions, political underpinnings, and mental and psychological impacts.

“My objective as an author is to inform people worldwide and refute the official narrative which has been used as a justification to destabilize the economic and social fabric of entire countries, followed by the imposition of the “deadly” COVID-19 “vaccine”. This crisis affects humanity in its entirety: almost 8 billion people. We stand in solidarity with our fellow human beings and our children worldwide. Truth is a powerful instrument.”

ISBN: 978-0-9879389-3-0,  Year: 2022,  PDF Ebook,  Pages: 164, 15 Chapters

Price: $11.50 Get yours for FREE! Click here to download.

We encourage you to support the eBook project by making a donation through Global Research’s DonorBox “Worldwide Corona Crisis” Campaign Page. 
Articles by: Brian Shilhavy

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]